Ken Griffin Icad Inc Transaction History

Citadel Advisors LLC

$509 Billion
Q1 2025

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Icad Inc stock. As of the latest transaction made, Citadel Advisors LLC holds 40,400 shares of ICAD stock, worth $152,308. This represents 0.0% of its overall portfolio holdings.

Number of Shares

40,400

Previous 17,500 130.86%

Holding current value

$152,308

Previous $32,000 159.38%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$1.87 - $3.69 $354,346 - $699,218	189,490 Added 438.4%	232,713 $479,000
Q4 2024 Feb 14, 2025	SELL	$1.39 - $2.4 $135,356 - $233,709	-97,379 Reduced 69.26%	43,223 $79,000
Q3 2024 Nov 14, 2024	BUY	$1.19 - $1.74 $99,957 - $146,156	83,998 Added 148.4%	140,602 $220,000
Q2 2024 Aug 14, 2024	SELL	$1.28 - $1.9 $13,376 - $19,855	-10,450 Reduced 15.58%	56,604 $73,000
Q1 2024 May 15, 2024	BUY	$1.35 - $2.27 $24,339 - $40,925	18,029 Added 36.78%	67,054 $107,000
Q4 2023 Feb 14, 2024	BUY	$1.27 - $2.06 $61,833 - $100,297	48,688 Added 14447.48%	49,025 $86,000
Q3 2023 Nov 14, 2023	BUY	$1.8 - $3.61 $606 - $1,216	337 New	337 $0
Q1 2023 May 15, 2023	SELL	$1.2 - $2.84 $54,584 - $129,183	-45,487 Reduced 89.22%	5,494 $6,000
Q4 2022 Feb 14, 2023	BUY	$1.6 - $2.37 $56,363 - $83,487	35,227 Added 223.61%	50,981 $93,000
Q3 2022 Nov 14, 2022	SELL	$2.04 - $4.32 $117,389 - $248,590	-57,544 Reduced 78.51%	15,754 $33,000
Q2 2022 Aug 15, 2022	BUY	$3.02 - $4.56 $221,359 - $334,238	73,298 New	73,298 $293,000
Q1 2022 May 16, 2022	SELL	$3.92 - $7.48 $46,220 - $88,196	-11,791 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$6.7 - $11.38 $82,289 - $139,769	-12,282 Reduced 51.02%	11,791 $0
Q3 2021 Nov 15, 2021	SELL	$10.11 - $17.56 $1.04 Million - $1.8 Million	-102,562 Reduced 80.99%	24,073 $259,000
Q2 2021 Aug 16, 2021	BUY	$14.9 - $20.82 $1.57 Million - $2.19 Million	105,036 Added 486.3%	126,635 $0
Q1 2021 May 17, 2021	BUY	$12.57 - $21.22 $21,884 - $36,944	1,741 Added 8.77%	21,599 $458,000
Q4 2020 Feb 16, 2021	SELL	$8.73 - $14.56 $626,194 - $1.04 Million	-71,729 Reduced 78.32%	19,858 $263,000
Q1 2020 May 15, 2020	BUY	$6.94 - $14.42 $394,983 - $820,699	56,914 Added 164.15%	91,587 $673,000
Q4 2019 Feb 14, 2020	BUY	$6.23 - $7.98 $122,201 - $156,527	19,615 Added 130.26%	34,673 $270,000
Q2 2019 Aug 14, 2019	BUY	$4.53 - $7.0 $68,212 - $105,406	15,058 New	15,058 $96,000

Others Institutions Holding ICAD

# of Institutions

Shares Held

8.01M

Call Options Held

67K

Put Options Held

40.2K

View Full List

About ICAD INC

Ticker ICAD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 25,333,900
Market Cap $95.5M
Description
iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, an...

More about ICAD

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account